Switzerland became a Gavi donor on December 2016 with the signing of an Agreement for a contribution of CHF 2 million in support to the 2016-2020 strategic period. As the host country of Gavi, Switzerland has been a strong supporter of Gavi's mission and vision since 2000.
In June 2020, Switzerland announced a major scale-up in its contribution with a new CHF 30 million pledge to support Gavi’s efforts to deliver life-saving vaccines to children in the world’s poorest countries. This contribution will support Gavi’s core programs during the 2021-2025 strategic period, as well as the COVAX AMC initiative, to finance and accelerate the research, development and production of a COVID-19 vaccine and its equitable distribution.
Health is a focus area of work across all Swiss Agency for Development and Cooperation (SDC) departments (east, global and regional cooperation and humanitarian aid), and its multilateral partnerships. Gavi’s mission to protect people’s health by increasing equitable use of vaccines in low-income countries is strongly aligned with the SDC’s strategic objective for fair access to resources and services, including health systems for all.
Switzerland is committed to the 2030 Agenda for Sustainable Development and was actively involved in the process to realise the SDGs. Switzerland’s support to Gavi emphasises their commitment to the achievement of the SDGs, and in particular the necessity of immunisation to achieve SDG3.
Contributions and pledges in total:
Note: Proceeds are funds made available to Gavi from donor contributions and commitments, either through cash payments made to Gavi, through frontloading via the capital markets of a future donor commitment to IFFIm, or through AMC funds released to Gavi via the World Bank. IFFIm proceeds are allocated over five-year periods coinciding with Gavi’s strategic periods. Proceeds for the current and future strategic periods are indicative until the end of each period and could be revised following changes in market conditions (interest rates or foreign exchange rates), the signing of new pledge(s) and/or changes in IFFIm’s disbursement profile.
Click on Direct, IFFIm, AMC or Matching Fund in the above key to toggle their data on the graph, click again to show the data
Direct Contributions (including Matching Fund)
Received contributions: non-US$ contributions for 2000-2019 and Q1-Q3 2020 are expressed in US$ equivalents using the exchange rates on the dates of receipt. For 2014-2019 and Q1-Q3 2020 where contributions were hedged to mitigate currency risk exposure, these have been expressed using the rates applicable to the hedge agreement.
Future contributions (for pledges made prior to the 4 June 2020 replenishment conference): non-US$ Direct Contribution and Matching Fund pledges for Q4-2020.
Future contributions (for pledges at the 4 June 2020 replenishment conference): non-US$ Direct Contribution and Matching Fund pledges for Q4-2020 and years
Future contributions: non-US$ contributions for Q4-2020 and for years 2021 and beyond are expressed in US$ equivalents as follows:
Where the contribution agreement has been signed: contributions are expressed in US$ equivalents using the exchange rates at the time of signing the respective donor grant agreements
Where the contribution agreement has not yet been signed: contributions are expressed in US$ equivalents using the applicable spot rates from Bloomberg as at 30 September 2020
Due to IFFIm’s nature as a frontloading vehicle, yearly contributions paid into IFFIm can differ significantly from yearly proceeds transferred to Gavi.
While IFFIm grants are irrevocable and legally binding, they are subject to a Grant Payment Condition that can potentially reduce the amount due in the event that a programme country is in protracted arrears with the International Monetary Fund. As of 30 September 2020, IFFIm donor grant payments are reduced by 0.5%, however such reductions are not reflected in future contributions figures.